Unknown

Dataset Information

0

Genotype-phenotype correlation of X-linked Alport syndrome observed in both genders: a multicenter study in South Korea.


ABSTRACT: The genotype-phenotype correlation of the X-linked Alport syndrome (XLAS) has been well elucidated in males, whereas it remains unclear in females. In this multicenter retrospective study, we analyzed the genotype-phenotype correlation in 216 Korean patients (male:female = 130:86) with XLAS between 2000 and 2021. The patients were divided into three groups according to their genotypes: the non-truncating group, the abnormal splicing group, and the truncating group. In male patients, approximately 60% developed kidney failure at the median age of 25.0 years, and kidney survival showed significant differences between the non-truncating and truncating groups (P < 0.001, hazard ratio (HR) 2.8) and splicing and truncating groups (P = 0.002, HR 3.1). Sensorineural hearing loss was detected in 65.1% of male patients, while hearing survival periods showed a highly significant difference between the non-truncating and truncating groups (P < 0.001, HR 5.1). In female patients, approximately 20% developed kidney failure at the median age of 50.2 years. The kidney survival was significantly different between the non-truncating and truncating groups (P = 0.006, HR 5.7). Our findings support the presence of genotype-phenotype correlation not only in male patients but also in female patients with XLAS.

SUBMITTER: Kim JH 

PROVIDER: S-EPMC10133262 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


The genotype-phenotype correlation of the X-linked Alport syndrome (XLAS) has been well elucidated in males, whereas it remains unclear in females. In this multicenter retrospective study, we analyzed the genotype-phenotype correlation in 216 Korean patients (male:female = 130:86) with XLAS between 2000 and 2021. The patients were divided into three groups according to their genotypes: the non-truncating group, the abnormal splicing group, and the truncating group. In male patients, approximatel  ...[more]

Similar Datasets

| S-EPMC2865738 | biostudies-literature
| S-EPMC5733817 | biostudies-literature
| S-EPMC6065097 | biostudies-literature
| S-EPMC6625365 | biostudies-literature
| S-EPMC7210609 | biostudies-literature
| S-EPMC6303895 | biostudies-literature
| S-EPMC11172428 | biostudies-literature
| S-EPMC1771890 | biostudies-literature
| S-EPMC11622270 | biostudies-literature
| S-EPMC8013505 | biostudies-literature